Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY05350 for Injection

About this update from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY05350 for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Huiyu Pharmaceutical Co. Ltd. Class A